NCT05626504View on ClinicalTrials.gov

Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

March 31, 2025

Conditions
Brain AneurysmIntracranial HemorrhagesStroke
Interventions
DEVICE

Pipeline Embolization Device with Vantage Technology

Flow-diverter device occludes aneurysms through endoluminal reconstruction and remodelling of the parent artery.

Trial Locations (1)

Unknown

Kings College Hospital, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER